Deep Brain Stimulation is a treatment which has been initiated in over a dozen neurological and neuropsychiatric conditions and disorders, yet the mechanism(s) underlying its efficacy are largely unknown and subject to much speculation. The procedure has also been reported to produce numerous instances of adverse effects, ranging from bleeding within the brain and infection to cognitive dysfunction, hallucinations, compulsivity and even depression. This symposium will address the current range of applications, efficacies, case studies, and the theory and modeling that attempt to uncover the biological underpinnings of its beneficial effects. The ultimate goal is to bring about a greater understanding of the means by which the beneficial effects are produced, at the molecular, cellular & network levels.
Invited Speakers
| Helen M. Bronte-Stewart, MD, MS | Cameron C. McIntyre, PhD |
| Joseph J. Fins, MD | Martha J. Morrell, MD |
| Benjamin Greenberg, MD, PhD | Jonathan E. Rubin, PhD |
| Jaimie M. Henderson, MD | Nicholas D. Schiff, MD |
| Kendall H. Lee, PhD, MD | Philip A. Starr, MD, PhD |
| Sarah Hollingsworth “Holly” Lisanby, MD | Michele Tagliati, MD |
| Helen S. Mayberg, MD | |
Keynote Address
Recipient of the 4th Annual Swartz Prize for Theoretical and Computational Neuroscience
Satellite Symposium Organizers
Cameron C. McIntyre, Cleveland Clinic Foundation
Dennis L. Glanzman, NIMH/NIH